Literature DB >> 9430365

The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.

M F Lopes-Virella1, N Binzafar, S Rackley, A Takei, M La Via, G Virella.   

Abstract

The incubation of human macrophages with antigen antibody complexes prepared with rabbit anti-LDL and human LDL (LDL-IC) is followed by ingestion of those immune complexes (IC), massive cholesterol ester accumulation, cytokine release and overexpression of the LDL receptor. The massive accumulation of cholesterol esters and overexpression of the native LDL receptor are specifically induced by immune complexes containing native or modified LDL, but not by any other type of IC. We report the results of a series of experiments aimed at defining the receptor preferentially involved in LDL-IC uptake. Flow cytometry studies using CD16, CD32 and CD64 monoclonal antibodies showed a sharp reduction on the expression of CD64 (Fc gamma RI) both by human monocyte-derived macrophages and THP-1 cells after incubation with LDL-IC, suggesting preferential engagement of this type of Fc receptor. Blocking experiments with aggregate-free IgG1 and CD32 monoclonal antibody confirmed that blocking Fc gamma RI prevented both LDL-IC uptake and the upregulation of LDL receptors on THP-1 cells. In contrast, blocking Fc gamma RII did not affect either the uptake of LDL-IC or the expression of LDL receptors on the same cells. The preferential engagement of Fc gamma R-I by LDL-IC suggests a biological difference of LDL-IC relative to other types of IC and opsonized particles. The precise molecular mechanism(s) responsible for the paradoxical upregulation of LDL receptor after the uptake of LDL-IC remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430365     DOI: 10.1016/s0021-9150(97)00157-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  24 in total

Review 1.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

Review 2.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

3.  Vitamin C supplementation reconstitutes polyfunctional T cells in streptozotocin-induced diabetic rats.

Authors:  Gamal Badr; Samir Bashandy; Hossam Ebaid; Mohamed Mohany; Douaa Sayed
Journal:  Eur J Nutr       Date:  2011-02-25       Impact factor: 5.614

4.  Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Authors:  Firoz Akhter; M Salman Khan; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

5.  Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.

Authors:  Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

6.  Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis.

Authors:  Igor A Sobenin; Vasily P Karagodin; Alexandra Capital A Cyrillic Melnichenko; Yuri V Bobryshev; Alexander N Orekhov
Journal:  J Clin Immunol       Date:  2012-10-17       Impact factor: 8.317

7.  The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.

Authors:  Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; Gabriel Virella; Thomas Moritz
Journal:  Atherosclerosis       Date:  2012-08-21       Impact factor: 5.162

8.  Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions.

Authors:  Alejandro Maldonado; Bryan A Game; Lanxi Song; Yan Huang
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 9.  Clinical significance of the humoral immune response to modified LDL.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Clin Immunol       Date:  2009-05-08       Impact factor: 3.969

10.  Antiatherosclerotic effects of the Fc portion of immunoglobulin in apolipoprotein E-deficient mice.

Authors:  Chiharu Kishimoto; Zuyi Yuan; Hideto Sano; Keisuke Shioji; Yang Xu; Masayuki Yokode
Journal:  Exp Clin Cardiol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.